The Argentine National Administration of Medicine, Foodstuff and Medical Devices (“ANMAT” for its acronym in Spanish) issued resolutions N° 2069/2018 and 3602/2018, updating the guidelines for good practices for the pharma industry.

These new guidelines constitute the gold standard for the industry regarding manufacturing, distribution and importation/exportation of medicines for human use.

The compliance with this regulation will be compulsory for pharma companies operating in the country.